Abstract
To balance children’s right to schooling with contagion management, knowing how school re-openings affect the spread of COVID-19 is crucial. This paper considers effects on testing and positive tests for COVID-19 of re-opening Norwegian schools after a six-week closure to reduce contagion. We estimate the effect of school reopening for teachers, parents and students using an event study/difference-in-differences design with comparison groups with minimal exposure to in-person schooling. We find no evidence that incidence increased following re-opening for either students, parents, or teachers pooled across grade levels. We find some suggestive evidence that infection rates among upper secondary school teachers increased; however, the effects are small and transitory. At low levels of contagion, schools can safely be re-opened when other social distancing policies remain in place.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Internal funding by the Norwegian Institute of public health
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approved by The Regional Committees for Medical and Health Research Ethics (REC) (#198964). Finn Wisloeff, Faculty of Medicine, University of Oslo Finn Skre Fjordholm, REK soeroest-D, REK, Oslo. Ethical approval was given
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
* Data made available by the Beredt C-19 emergency preparedness registry have been essential for the project. We are grateful to Atle Fretheim, Margrethe Greve-Isdahl and Kjetil Telle for helpful discussions, suggestions and comments.
E-mail: AnnaAasen.Godoy{at}fhi.no
E-mail: MajaWeemes.Grotting{at}fhi.no
E-mail: RannveigKaldager.Hart{at}fhi.no
Data Availability
Sensitive data kept in repository
